Home > Healthcare > Medical Devices > Diagnostic Devices > High Pressure Contrast Media Injectors Market

High Pressure Contrast Media Injectors Market Size

Report ID: GMI6087
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

High Pressure Contrast Media Injectors Market Size

High Pressure Contrast Media Injectors Market size was valued at USD 176.4 million in 2022 and is estimated to account for USD 551.1 million by 2032. High-pressure contrast media injectors, also known as high-pressure syringe injectors or power injectors are medical devices used in radiology procedures to administer contrast media into the patient's body.

To get key market trends

Download Free Sample

Contrast media are substances that enhance the visibility of anatomical structures or blood vessels during imaging studies such as computed tomography (CT) scans, angiography, or magnetic resonance imaging (MRI). Increasing prevalence of numerous diseases such as cancer, neurological and cardiovascular diseases that require diagnostic imaging procedures will contribute to the demand for high pressure contrast media injectors. Additionally, technological advancements in imaging agents and the need for accurate and detailed diagnostic information.

High Pressure Contrast Media Injectors Market Report Attributes
Report Attribute	Details
Base Year:	2022
High Pressure Contrast Media Injectors Market Size in 2022:	USD 176.4 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	12.1%
2032 Value Projection:	USD 551.1 Million
Historical Data for:	2018 to 2022
No. of Pages:	256
Tables, Charts & Figures:	449
Segments covered:	Product, Type, Application, End-use and Region
Growth Drivers:	Rising prevalence cancer & cardiovascular diseases Technological advancements Increasing applications of contrast media injectors in neurosurgery and orthopaedic surgery
Pitfalls & Challenges:	High cost of contrast injector

Learn more about the key segments shaping this market

Download Free Sample

Moreover, technological advancements in medical imaging modalities such as CT scans, angiography, and MRI. These advancements enable more precise and detailed imaging requiring efficient and high-pressure injectors to deliver contrast media effectively, thereby positively influencing product demand. Furthermore, rising demand for real time imaging and contrast-enhanced imaging in the diagnostic procedure to improve image quality, including higher resolution, faster acquisition time, and reduced artifacts.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

High pressure contrast media injectors industry was worth USD 176.4 million in 2022 and is estimated to generate USD 551.1 million by 2032, driven by the high incidence rate of numerous diseases along with that the rising requirement for diagnostic imaging procedures.

The consumables segment is set to grow at 11.9% CAGR by 2032 attributed to the rising prevalence of chronic diseases and the growing need for accurate diagnosis and treatment monitoring.

U.S. industry size reached USD 62.9 million in 2022 and is estimated to record considerable growth from 2023-2032 owing to the ongoing advancements in imaging technologies and the growing shift towards minimally invasive procedures.

Bracco Group, Medtron AG, Guerbet Group, Bayer HealthCare LLC, NemotoKyorindo Co., Ltd., ulrich GmbH & Co. KG, GE Healthcare, Apollo RT Co. Ltd., Sino Medical-Device Technology Co., and VIVID IMAGING are some of the major enterprises in the industry.